TY - JOUR
T1 - Damaging variants in FOXI3 cause microtia and craniofacial microsomia
AU - Quiat, Daniel
AU - Timberlake, Andrew T.
AU - Curran, Justin J.
AU - Cunningham, Michael L.
AU - McDonough, Barbara
AU - Artunduaga, Maria A.
AU - DePalma, Steven R.
AU - Duenas-Roque, Milagros M.
AU - Gorham, Joshua M.
AU - Gustafson, Jonas A.
AU - Hamdan, Usama
AU - Hing, Anne V.
AU - Hurtado-Villa, Paula
AU - Nicolau, Yamileth
AU - Osorno, Gabriel
AU - Pachajoa, Harry
AU - Porras-Hurtado, Gloria L.
AU - Quintanilla-Dieck, Lourdes
AU - Serrano, Luis
AU - Tumblin, Melissa
AU - Zarante, Ignacio
AU - Luquetti, Daniela V.
AU - Eavey, Roland D.
AU - Heike, Carrie L.
AU - Seidman, Jonathan G.
AU - Seidman, Christine E.
N1 - Funding Information:
We thank the patients and parents for their participation in this research and the Microscopy Resources on the North Quad (MicRoN) core at Harvard Medical School for imaging assistance. This work was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders grant R00DC011282 (to D.V.L.), National Institutes of Health National Institute of Dental and Craniofacial Research grant RC1 DE 020270 (to C.L.H.), National Institutes of Health National Institute of Child Health and Human Development grant X01 HL140518-01 (to D.V.L.), National Institutes of Health National Institute of Dental and Craniofacial Research grant U01 DE025862 (to D.V.L. and C.L.H.), the Jean Renny Endowment for Craniofacial Research grant (to M.L.C.), National Institutes of Health National Institute of Child Health and Human Development grant HL145690-01 (to J.G.S.), Fondation Leducq grant 16-CVD03 (to J.G.S. and C.E.S.), and a Howard Hughes Medical Institute grant (to C.E.S.).
Funding Information:
We thank the patients and parents for their participation in this research and the Microscopy Resources on the North Quad (MicRoN) core at Harvard Medical School for imaging assistance. This work was supported by National Institutes of Health National Institute on Deafness and Other Communication Disorders grant R00DC011282 (to D.V.L.), National Institutes of Health National Institute of Dental and Craniofacial Research grant RC1 DE 020270 (to C.L.H.), National Institutes of Health National Institute of Child Health and Human Development grant X01 HL140518-01 (to D.V.L.), National Institutes of Health National Institute of Dental and Craniofacial Research grant U01 DE025862 (to D.V.L. and C.L.H.), the Jean Renny Endowment for Craniofacial Research grant (to M.L.C.), National Institutes of Health National Institute of Child Health and Human Development grant HL145690-01 (to J.G.S.), Fondation Leducq grant 16-CVD03 (to J.G.S. and C.E.S.), and a Howard Hughes Medical Institute grant (to C.E.S.). Conceptualization: D.Q. A.T.T. R.D.E. D.V.L. C.L.H. J.G.S. C.E.S.; Data Curation: B.M.; Investigation: D.Q. A.T.T. J.J.C. M.L.C. J.A.G. M.A.A. S.R.D. J.M.G. L.Q.-D. Y.N.; Resources: U.H. L.S. G.O. R.D.E. M.T. M.M.D.-R. P.H.-V. H.P. G.L.P.-H. I.Z.; Funding Acquisition: M.T. R.D.E. D.V.L. C.L.H. J.G.S. C.E.S.; Writing-original draft: D.Q. A.T.T.; Writing-reviewing and editing: D.Q. A.T.T. M.L.C. D.V.L. C.L.H. J.G.S. C.E.S. All human studies were reviewed and approved by the Institutional Review Board of the Seattle Children's Hospital or the Partners Human Research Committee, Institutional Review Board of Partners Healthcare (Brigham and Women's Hospital, Boston, MA), and each of the local institutions’ institutional review boards. An informed consent form was signed by all individuals, and explicit written consent was provided for publication of clinical images.
Publisher Copyright:
© 2022 The Authors
PY - 2023/1
Y1 - 2023/1
N2 - Purpose: Craniofacial microsomia (CFM) represents a spectrum of craniofacial malformations, ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve. The genetic causes of CFM remain largely unknown. Methods: We performed genome sequencing and linkage analysis in patients and families with microtia and CFM of unknown genetic etiology. The functional consequences of damaging missense variants were evaluated through expression of wild-type and mutant proteins in vitro. Results: We studied a 5-generation kindred with microtia, identifying a missense variant in FOXI3 (p.Arg236Trp) as the cause of disease (logarithm of the odds = 3.33). We subsequently identified 6 individuals from 3 additional kindreds with microtia-CFM spectrum phenotypes harboring damaging variants in FOXI3, a regulator of ectodermal and neural crest development. Missense variants in the nuclear localization sequence were identified in cases with isolated microtia with aural atresia and found to affect subcellular localization of FOXI3. Loss of function variants were found in patients with microtia and mandibular hypoplasia (CFM), suggesting dosage sensitivity of FOXI3. Conclusion: Damaging variants in FOXI3 are the second most frequent genetic cause of CFM, causing 1% of all cases, including 13% of familial cases in our cohort.
AB - Purpose: Craniofacial microsomia (CFM) represents a spectrum of craniofacial malformations, ranging from isolated microtia with or without aural atresia to underdevelopment of the mandible, maxilla, orbit, facial soft tissue, and/or facial nerve. The genetic causes of CFM remain largely unknown. Methods: We performed genome sequencing and linkage analysis in patients and families with microtia and CFM of unknown genetic etiology. The functional consequences of damaging missense variants were evaluated through expression of wild-type and mutant proteins in vitro. Results: We studied a 5-generation kindred with microtia, identifying a missense variant in FOXI3 (p.Arg236Trp) as the cause of disease (logarithm of the odds = 3.33). We subsequently identified 6 individuals from 3 additional kindreds with microtia-CFM spectrum phenotypes harboring damaging variants in FOXI3, a regulator of ectodermal and neural crest development. Missense variants in the nuclear localization sequence were identified in cases with isolated microtia with aural atresia and found to affect subcellular localization of FOXI3. Loss of function variants were found in patients with microtia and mandibular hypoplasia (CFM), suggesting dosage sensitivity of FOXI3. Conclusion: Damaging variants in FOXI3 are the second most frequent genetic cause of CFM, causing 1% of all cases, including 13% of familial cases in our cohort.
KW - Craniofacial microsomia
KW - Ectoderm
KW - FOXI3
KW - Microtia
KW - Neural crest
UR - http://www.scopus.com/inward/record.url?scp=85140063939&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140063939&partnerID=8YFLogxK
U2 - 10.1016/j.gim.2022.09.005
DO - 10.1016/j.gim.2022.09.005
M3 - Article
C2 - 36260083
AN - SCOPUS:85140063939
SN - 1098-3600
VL - 25
SP - 143
EP - 150
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 1
ER -